Cargando…
Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma
Multiple Myeloma (MM), a clonal malignancy of antibody-producing plasma cells, is the second most common hematologic malignancy and results in significant patient morbidity and mortality. The high degree of immune dysregulation in MM, including T cell imbalances and up-regulation of immunosuppressiv...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802552/ https://www.ncbi.nlm.nih.gov/pubmed/29208938 http://dx.doi.org/10.1038/s41408-017-0020-0 |